Skip to content

NOTICIERO VOIDVOID TERMINAL

AI Web3 Crypto Stocks Finance Macro Prediction Markets Technology Markets Newsletter

PRO

Front page › Markets

Markets

Actuate Therapeutics CEO Daniel Schmitt purchases $49,999 in stock

Investing.com1 Nov 2026, 06:31 UTC

Read the full story at Investing.com

Related

El director ejecutivo de Truist Financial compra acciones por 1,2 millones de dólares Investing.com España
Truist Financial CEO Michael Lyons buys $1.2M in company stock Investing.com
El director ejecutivo de Actuate Therapeutics compra 49.999 dólares en acciones Investing.com España
Binance to resume crypto withdrawals in phases after record $6 billion hack Investing.com
Binance reanudará los retiros de criptomonedas por fases tras el hackeo récord de 6.000 millones de dólares Investing.com España
Director de Bank First Corp compra 59.348 dólares en acciones Investing.com España
Bank First Corp director Sprang buys $59,348 of common stock Investing.com
OneKey founder warns older iPhones have unpatchable chip vulnerabilities Crypto Briefing

Economy & Central Banks · AI · Markets · Crypto · Web3 · Stocks · Technology · Finance · Commodities · Currencies · Geopolitics · All news · About · Editorial policy · Privacy

NOTICIERO VOID ·

Economy · Markets · Crypto · Commodities · Currencies · Geopolitics · About · Editorial policy · Privacy · RSS

Data: FRED (St. Louis Fed), U.S. Treasury FiscalData, Federal Reserve, ECB, BEA, CoinGecko, DefiLlama, GeckoTerminal, OKX, Solana RPC and publisher RSS feeds. Headlines link to the original publishers. Keyboard: g then t/m/n/c to jump · / search.